Table 3 Correlation between thioredoxin and other variables among HCC and cirrhosis groups
From: Evaluation of serum thioredoxin as a hepatocellular carcinoma diagnostic marker
Parameter | Thioredoxin | |||
|---|---|---|---|---|
HCC group | Cirrhosis group | |||
r | P value | r | P value | |
Hemoglobin | 0.128 | 0.541 | -0.204 | 0.465 |
White blood cells | -0.101 | 0.632 | -0.042 | 0.880 |
Platelets | -0.134 | 0.522 | 0.317 | 0.249 |
Alanine aminotransferase | -0.137 | 0.513 | -0.673 | 0.006 |
Aspartate aminotransferase | -0.511 | 0.009 | -0.074 | 0.794 |
Alkaline phosphatase | -0.002 | 0.990 | 0.162 | 0.563 |
Gamma Glutamyl transferase | 0.205 | 0.326 | -0.261 | 0.347 |
Total bilirubin | -0.217 | 0.298 | -0.472 | 0.076 |
Direct bilirubin | -0.094 | 0.656 | -0.458 | 0.086 |
Albumin | 0.075 | 0.723 | 0.154 | 0.583 |
Prothrombin time | -0.116 | 0.582 | 0.303 | 0.273 |
Alpha fetoprotein | 0.109 | 0.603 | 0.178 | 0.526 |
Age | -0.006 | 0.975 | 0.497 | 0.063 |